Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug (Q39653805)

13 September 2017

title

Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug (English)

1 reference

13 September 2017

0 references

Ashay Jain

1

1 reference

13 September 2017

Abhinav Agarwal

2

1 reference

13 September 2017

Saikat Majumder

3

1 reference

13 September 2017

Narendra Lariya

4

1 reference

13 September 2017

Anil Khaya

5

1 reference

13 September 2017

Himanshu Agrawal

6

1 reference

13 September 2017

Subrata Majumdar

7

1 reference

13 September 2017

Govind P. Agrawal

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20854859

16 July 2024

language of work or name

English

0 references

publication date

17 September 2010

1 reference

full work available at URL

13 September 2017

https://api.elsevier.com/content/article/PII:S0168365910007467?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

https://api.elsevier.com/content/article/PII:S0168365910007467?httpAccept=text/plain

16 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Journal of Controlled Release

16 July 2024

published in

1 reference

13 September 2017

volume

148

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

359-367

1 reference

Ligand based dendritic systems for tumor targeting

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Tumour and dendrimers: a review on drug delivery aspects.

16 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Dendrimers in biomedical applications--reflections on the field

16 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Glycoprotein glycosylation and cancer progression

16 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Mannosylated niosomes as adjuvant-carrier system for oral mucosal immunization.

16 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers

16 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice.

16 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Assessment of targeting potential of galactosylated and mannosylated sterically stabilized liposomes to different cell types of mouse liver

16 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Receptor mediated glycotargeting

16 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis

16 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome

16 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Paclitaxel-loaded poly(L-lactic acid) microspheres 3: blending low and high molecular weight polymers to control morphology and drug release

16 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles

16 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel

16 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies

16 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Reversal of multidrug resistance in HL-60 cells by verapamil and liposome-encapsulated doxorubicin

16 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Nanoparticles as novel carrier for brain delivery: a review

16 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Biodegradable polymeric nanoparticles as drug delivery devices

16 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Phagocytic uptake and cytotoxicity of solid lipid nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407.

16 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Solid lipid nanoparticles (SLN) for controlled drug delivery--drug release and release mechanism.

16 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization.

16 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant

16 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

16 July 2024

Liposomal doxorubicin

37

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Dextran conjugated dendritic nanoconstructs as potential vectors for anti-cancer agent.

16 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Solvent injection as a new approach for manufacturing lipid nanoparticles--evaluation of the method and process parameters

16 July 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Pharmacokinetics and biodistribution studies of Doxorubicin loaded poly(butyl cyanoacrylate) nanoparticles synthesized by two different techniques

16 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

A PEGylated dendritic nanoparticulate carrier of fluorouracil

16 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers

16 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies

16 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells

16 July 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Targeting and inhibition of cell growth by an engineered dendritic nanodevice

16 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate

16 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.

16 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Protective effect of Zingiber officinale roscoe against anticancer drug doxorubicin-induced acute nephrotoxicity

16 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas

16 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery

16 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate.

16 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting

16 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules

16 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Cellular uptake and cytotoxicity of solid lipid nanospheres (SLN) incorporating doxorubicin or paclitaxel

16 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier

16 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.JCONREL.2010.09.003

16 July 2024

Identifiers

1 reference

13 September 2017

1 reference